New antibiotic candidate enters first human safety trial
NCT ID NCT07500181
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing a new experimental antibiotic, BAL2420, in 136 healthy adults. The goal is to check if it is safe and how the body processes it. Researchers will give single or multiple doses and watch for side effects. This is a first step toward possibly using it to treat severe bacterial infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BAL2420 (an experimental antibiotic)
What this could lead to
If successful, this could lead to a new treatment option for serious infections caused by Gram-negative bacteria.
What could go wrong
This is a very early Phase 1 safety study in healthy people, not patients. The drug may not work or may have side effects. Many early-stage drugs never reach the market.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Early Clinical & Bioanalytical Solutions
RECRUITINGGroningen, 9728 NZ, Netherlands